Pharma News, Research & Solutions CSR News

These 6 University Researchers Are Ready to Change the World With Their Inventions

They're the winners of the second annual Johnson & Johnson WiSTEM2D Scholars Award, thanks to such amazing innovations as tattoos that can monitor changes in your metabolism. Meet them and their groundbreaking work.
Article

A better, smarter 3-D printer. A gel that could speed up wound healing—and minimize scarring. Tattoos that could monitor your metabolism.

These are just a sampling of the big ideas the winners of Johnson & Johnson’s second annual WiSTEM2D Scholars Award Program are hoping to one day bring to market.

Dr. Monika Lessl to Lead Both the Bayer Science and the Bayer Cares Foundations

Press Release

LEVERKUSEN, Germany, April 18, 2019 /3BL Media/ – Bayer’s Board of Management has appointed Dr. Monika Lessl as Bayer Foundations’ executive committee member to lead both the Bayer Science Foundation and the Bayer Cares Foundation. This role will be integrated into her current leadership of Bayer’s Corporate Innovation and R&D function.

Do People in Developing Countries Have Access to Bayer Drug Products As Well?

Blog

Millions of people in developing countries have no access to medicines. In some cases they cannot afford them, while in others there simply are no markets and no functioning healthcare system. We are working to provide help in a number of ways. With our contraception access programs, for example, we aim to make self-determined family planning available to women in order to reduce maternal and infant mortality.

Thought Leaders Emphasize Cattle Health and Well-Being for the Sustainable Development of the Beef Industry

More than 220 cattle professionals engage over key topics of parasite control, bovine respiratory disease, reproduction, digital innovation and well-being at the 2nd Bayer International Beef Symposium
Press Release

MONHEIM, Germany & RIBEIRÃO PRETO, Brazil, April 10, 2019 /3BL Media/ – Bayer brought together global thought leaders in beef cattle health and management to share the latest in research and innovation at its 2nd International Beef Symposium in Ribeirão Preto, Brazil from 31st March to 2nd April. 

Novartis Joins the Global Chagas Disease Coalition and Also Announces First Multinational, Prospective, Randomized Study in People With Chronic Chagas Cardiomyopathy

Summary: 
  • Study is planned to assess efficacy and safety of Entresto® (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019
  • Chagas disease is a potentially life-threatening neglected disease, affecting approximately six million people worldwide1,2, mostly in Latin America; up to 30% of chronically infected people develop cardiac disorders3
  • Chagas cardiomyopathy is the most important clinical manifestation of the disease, resulting in the majority of morbidity and mortality4
  • The Global Chagas Disease Coalition is a collaborative alliance, which aims to increase awareness of Chagas disease and foster synergies in controlling the disease and promoting access to diagnosis and treatment5
Press Release
  • Study is planned to assess efficacy and safety of Entresto® (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019
  • Chagas disease is a potentially life-threatening neglected disease, affecting approximately six million people worldwide1,2, mostly in Latin America; up to 30% of chronically infected people develop cardiac disorders3
  • Chagas cardiomyopathy is the most important clinical manifestation of the disease, resulting in the majority of morbidity and mortality4
  • The Global Chagas Disease Coalition is a collaborative alliance, which aims to increase awareness of Chagas disease and foster synergies in controlling the disease and promoting access to diagnosis and treatment5

VIDEO | Aflac Cancer Center: Ethan's Story

Multimedia with summary

Kids like Ethan are why Aflac has been a corporate ally for the childhood cancer community for 24 years. Through innovative research and helping provide peace of mind to patients and their families, Aflac’s commitment to helping find a cure for pediatric cancer holds strong. Every child deserves a lifetime.

About Aflac

Novo Nordisk Publishes Integrated 2018 Annual Report

Article

Novo Nordisk has published its integrated 2018 Annual Report detailing the company’s year-end performance. The report highlights the company’s progression towards long-term targets taking an integrated approach that accounts for financial, social and environmental performance. This is the company’s 15th integrated report.

J&J Exec: Tuberculosis is a Global Emergency. It's Time to Start Treating it That Way

By Paul Stoffels
Summary: 
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
Article
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.

Meet a Johnson & Johnson Researcher Poised to Crack the HIV Vaccine Code

In the lead-up to the recent International AIDS Society Conference on HIV Science in the Netherlands, we sat down with Hanneke Schuitemaker, who's hard at work on the holy grail of HIV research: a preventive treatment.
Article

By Sheila Weller

In 1992, as a young HIV/AIDS researcher in her native Netherlands, Hanneke Schuitemaker, Ph.D., now Vice President, Global Head of Viral Vaccine Discovery and Translational Medicine, Janssen Vaccines & Prevention B.V., was devoted to learning as much as she could about the disease—and saw her role as that of a researcher, rather than someone who closely interacted with people who were living with HIV.

But that quickly changed.

Astellas Brings Light to the Lives of Cancer Patients

Blog
At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma.
 

Pages

Subscribe to Pharma News, Research & Solutions